Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sevion Therapeutics Inc (OTCQB:SVON)

0.269
Delayed Data
As of May 26
 +0.0465 / +20.90%
Today’s Change
0.08
Today|||52-Week Range
0.30
+91.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization12.4K11.6K14.0K9.4K
 
 
 
 
 
 
Operating ExpensesGross Income-12.4K-11.6K-14.0K-9.4K
 
 
 
 
 
General Expenses612.8K674.6K493.5K332.5K
 
 
 
 
 
Other Operating Expenses71.4K74.0K0.000.00
 
 
 
Research And Development398.1K268.6K193.4K117.3K
 
 
 
 
 
Total Operating Expenses696.5K760.3K507.5K341.9K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-696.5K-760.3K-507.5K-341.9K
 
 
 
 
 
Extraordinary Credit0.00637.0K319.5K55.6K
 
 
 
 
Extraordinary Charge-736.0K-1.5M-1.0M0.00
 
 
 
 
Interest Expense On Debt0.000.001.9K54.0K
 
 
 
Other Expenses-162.00-74.000.00-1.7M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.4M-1.6M-1.2M-2.1M
 
 
 
 
 
Income Taxes-280.0K-640.0K-400.0K0.00
 
 
 
 
Preferred Dividend-7.2K-9.5K-15.8K-9.0K
 
 
 
 
 
Net Income-1.2M-933.6K-789.8K-2.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.5M20.5M20.7M23.5M
 
 
 
 
 
Shares To Calculate EPS Diluted20.5M20.5M20.7M23.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.05-$0.04-$0.09
 
 
 
 
 
EPS Diluted-$0.06-$0.05-$0.04-$0.09